UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 28, 2022 11:00 A.M.
Form:
F-3
CIK:
0001018735
Company Name:
NYMOX PHARMACEUTICAL CORP
File Number:
333-261571